{"id":"W3003995118","doi":"10.1002/ehf2.12555","title":"Highlights in Heart Failure","year":2019,"lang":"en","type":"review","venue":"ESC Heart Failure","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":263,"is_retracted":false,"has_abstract":true,"ca_institutions":"Surgical Specialties (Canada)","funders":"","keywords":"Medicine; Heart failure; Internal medicine; Hazard ratio; Ejection fraction; Clinical endpoint; Sacubitril; Dapagliflozin; Enalapril; Cardiology; Decompensation; Valsartan; Ranolazine; Placebo; Confidence interval; Hyperkalemia; Adverse effect; Randomized controlled trial; Blood pressure; Type 2 diabetes; Diabetes mellitus; Endocrinology; Angiotensin-converting enzyme","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.000267094,0.0007461022,0.003177075,0.0006105524,0.0000534856,0.00006901431,0.0002059371,0.0005978457,0.0008810682],"category_scores_gemma":[0.00003241084,0.0005491307,0.0008747838,0.0006363165,0.00004838147,0.0001306444,0.0001628332,0.00067803,0.008181564],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003308833,"about_ca_system_score_gemma":0.0003304592,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00003604116,"about_ca_topic_score_gemma":0.00009832754,"domain_scores_codex":[0.9970623,0.000149518,0.0007130229,0.0008547171,0.0004766904,0.0007437887],"domain_scores_gemma":[0.9983648,0.0001119821,0.000139823,0.001077072,0.00004877495,0.0002575135],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","study_design_scores_codex":[0.000009774594,0.0003951256,0.0003221917,0.03009651,0.0005400674,0.0001319865,0.00004331531,3.335044e-7,0.000002372214,0.001168122,0.8736736,0.09361657],"study_design_scores_gemma":[0.0009616805,0.0002425889,0.00007424236,0.01798992,0.001308188,0.00004320496,0.00001871725,9.713525e-7,0.000003501919,0.00001150953,0.9788918,0.0004536938],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.00002584674,0.9792113,0.000001156881,0.01458379,0.0004795579,0.003345758,0.00002496639,0.0001698579,0.002157809],"genre_scores_gemma":[0.00003165238,0.9724643,0.003538058,0.0007507222,0.0005656681,0.0003405153,0.0006489107,0.0001549676,0.02150525],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.1052181,"threshold_uncertainty_score":0.999696,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.030302811380363,"score_gpt":0.3088280836124762,"score_spread":0.2785252722321132,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}